Clinical trials for Astrocytoma
51 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT07552467Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant TumorsUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology · PI: Xiaoli Lan, PhD
- RECRUITINGPhase 2NCT05653635Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II StudyCentre Paul Strauss
- RECRUITINGEarly Phase 1NCT07284069Senicapoc and Perampanel for Newly Diagnosed GlioblastomaAarhus University Hospital
- RECRUITINGPhase 1NCT07343986Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated GlioblastomaUniversity of Virginia · PI: Camilo Fadul, M.D.
- RECRUITINGPhase 2NCT07417761Tuvusertib in Astrocytoma With ATRX MutationGrupo Español de Investigación en Neurooncología · PI: Estela Pineda, M.D.; Ph.D.
- RECRUITINGN/ANCT06466031Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO]Copernicus Memorial Hospital · PI: Kamil Krystkiewicz, PhD
- RECRUITINGN/ANCT06930846HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)Dartmouth-Hitchcock Medical Center · PI: Elaine T Kiriakopoulos, MD, MPH, MSc
- RECRUITINGPhase 3NCT07100730Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent GlioblastomaTelix Pharmaceuticals (Innovations) Pty Limited
- RECRUITINGPhase 2NCT07476794Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatomaSunnybrook Health Sciences Centre
- RECRUITINGPhase 3NCT07461948Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma PatientsJonsson Comprehensive Cancer Center · PI: Jingwen Yao
- RECRUITINGPhase 1NCT06815432GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive GlioblastomaBaylor College of Medicine · PI: Ganesh Rao, MD
- RECRUITINGPhase 1NCT07193628B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory GlioblastomaSecond Affiliated Hospital, School of Medicine, Zhejiang University · PI: Feng Yan, MD & PhD
- RECRUITINGPhase 2NCT06776250Study of How Safe and Effective Tarlatamab is in Brain CancersUniversity Health Network, Toronto · PI: Eric Chen, MD
- RECRUITINGPhase 2NCT06356883Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing GlioblastomaUniversité de Sherbrooke · PI: David Fortin, MD
- RECRUITINGPhase 1NCT06894979Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine GliomaChildren's Oncology Group · PI: Erin K Barr
- RECRUITINGEarly Phase 1NCT06613841Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of GlioblastomaAbramson Cancer Center at Penn Medicine · PI: Ali Nabavizadeh, MD
- RECRUITINGPhase 2NCT06835803Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized TrialBrigham and Women's Hospital
- RECRUITINGN/ANCT06533163Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot TrialBioTex, Inc. · PI: Frank Giordano, MD
- RECRUITINGEarly Phase 1NCT07538128Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent GlioblastomaHuashan Hospital · PI: Zhifeng Shi, Dr.
- RECRUITINGEarly Phase 1NCT06757153Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma PatientsZhongnan Hospital · PI: Zhiqiang Li
- RECRUITINGPHASE1, PHASE2NCT06622434New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a StudyAssistance Publique - Hôpitaux de Paris · PI: Antoine CARPENTIER, Pr
- RECRUITINGPHASE1, PHASE2NCT06329570Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)NaviFUS Corporation
- RECRUITINGNCT06915649Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational ApproachUniversity Hospital, Montpellier · PI: Gaetan POULEN, MD, PhD
- RECRUITINGN/ANCT06551909Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)IRCCS San Raffaele · PI: Nadia G Di Muzio, Prof
- RECRUITINGPhase 1NCT06585527Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant GliomaBeijing Neurosurgical Institute · PI: Fusheng Liu, MD,PhD
- RECRUITINGPhase 2NCT06061809N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive GlioblastomaImmunityBio, Inc.
- ACTIVE NOT RECRUITINGPhase 2NCT06336291A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or RecurrencePhilogen S.p.A.
- RECRUITINGN/ANCT05990556Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma PatientsFirst Affiliated Hospital, Sun Yat-Sen University · PI: Nu Zhang, Professor
- RECRUITINGPHASE1, PHASE2NCT06157541T Cells and Pembrolizumab for Recurrent and Newly Diagnosed GlioblastomaQueensland Institute of Medical Research · PI: Rajiv Khanna, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT05986851Azeliragon in MGMT Unmethylated GlioblastomaCantex Pharmaceuticals · PI: Stephen G Marcus, MD
- RECRUITINGPhase 1NCT05879367Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or AstrocytomaOrbus Therapeutics, Inc. · PI: Howard Colman, MD, PhD
- ACTIVE NOT RECRUITINGPhase 1NCT05561374Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade GliomaOblato, Inc.
- RECRUITINGPhase 2NCT05607407Methimazole in Patients With Progressive GlioblastomaCase Comprehensive Cancer Center · PI: David Peereboom, MD
- ACTIVE NOT RECRUITINGPhase 1NCT05484622Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant GliomaInstitut de Recherches Internationales Servier
- RECRUITINGPhase 2NCT06297512Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).Iacopo Sardi · PI: Iacopo Sardi
- RECRUITINGPHASE1, PHASE2NCT05590689Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain TumorUniversität Münster · PI: Walter Stummer, Prof. Dr.
- ACTIVE NOT RECRUITINGPhase 1NCT05236036Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of GlioblastomaNorthwestern University · PI: Priya U Kumthekar, MD
- ACTIVE NOT RECRUITINGPhase 1NCT05222802A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)Katmai Pharmaceuticals Inc. · PI: Les Brail
- ACTIVE NOT RECRUITINGNCT04007185Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)Cambridge University Hospitals NHS Foundation Trust · PI: Stephen J Price, PhD FRCS
- RECRUITINGPhase 1NCT04678648A Trial of RSC-1255 for Treatment of Patients With Advanced MalignanciesRasCal Therapeutics, Inc. · PI: Michael Mann, MD
- ACTIVE NOT RECRUITINGEarly Phase 1NCT04614909Study of Pamiparib in Newly Diagnosed and rGBMNader Sanai · PI: Nader Sanai, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04469075Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating FieldsMemorial Sloan Kettering Cancer Center · PI: Alina Markova, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04221503Niraparib/TTFields in GBMAbramson Cancer Center at Penn Medicine
- ACTIVE NOT RECRUITINGPhase 1NCT04047706Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaNorthwestern University · PI: Rimas V Lukas, MD
- RECRUITINGN/ANCT04479696Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain TumorsM.D. Anderson Cancer Center · PI: Caroline Chung
- RECRUITINGN/ANCT03861299The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.Jasper Gerritsen · PI: Arnaud Vincent, MD PhD
- ACTIVE NOT RECRUITINGPhase 1NCT03587038OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed GlioblastomaUniversity of Oklahoma · PI: James Battiste, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04195139Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBMUniversity of Sydney · PI: Mustafa Khasraw
- RECRUITINGNCT04648462Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncologyMaastricht Radiation Oncology · PI: Danielle Eekers
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03277638Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)Case Comprehensive Cancer Center · PI: Tiffany Hodges, MD
- RECRUITINGPHASE1, PHASE2NCT02704858Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated GliomaNeonc Technologies, Inc. · PI: Thomas Chen, MD, PhD